Wall St futures steady after weekly gains; Fed rate decision looms
Phyllis Gotlib, President, International at American Well Corp (NYSE:AMWL), sold 4,781 shares of Class A Common Stock on September 2, 2025, at a price of $6.7815, for a total of $32,422. The transaction comes as AMWL trades near $6.72, down about 23% over the past six months, though InvestingPro analysis suggests the stock is currently undervalued.
Following the transaction, Gotlib directly owns 132,110 shares of American Well Corp . She also indirectly owns 114,250 shares through her husband. The company maintains a strong balance sheet, holding more cash than debt with a healthy current ratio of 3.29x.
The sale was executed to cover the tax liability resulting from the vesting and settlement of restricted stock units on September 1, 2025, and was not a discretionary trade by Gotlib. For comprehensive insider trading analysis and additional financial insights, explore InvestingPro, which offers exclusive research reports on over 1,400 US stocks.
In other recent news, Amwell reported a notable increase in total revenue for the second quarter of 2025, reaching $70.9 million, which marks a 13% rise compared to the same period last year. This improvement in financial performance is attributed to the company’s strategic initiatives in AI and digital healthcare solutions. Additionally, Wells Fargo adjusted its price target for Amwell to $12 from $15, citing revised long-term revenue projections based on its discounted cash flow model. Despite this adjustment, Wells Fargo maintained an Overweight rating on the stock. These developments highlight the evolving financial landscape for Amwell as it continues to focus on growth and innovation in the telehealth sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.